The Patent Finder

Gongwin Biopharm Co., Ltd.

Also on record
Records under this name other than the patents Gongwin Biopharm Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 4 of 4 · Back to Gongwin Biopharm Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,668,990Benzenesulfonamides compositions for treatment of malignant pleural effusions
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,182,998Benzenesulfonamide compositions for treatment of malignant pleural effusions
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,782,370Novel Pharmaceutical Compositions of Benzenesulfonamide Derivatives for Treatment of Adenoid Cystic Carcinoma
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,485,773Benzenesulfonamide Derivatives and Method for Treating Cancer
Formerly held
In force
 · Medium confidence
In forceMedium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited